Amgen Inc.
AMGN
Jodie situation report
Amgen Inc.'s current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 15 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 31 directly disclosed connections are confirming.
- Revenue increased 9.5% versus the comparable filing period.
- Capital expenditures for the quarter were $712M vs $411M, including construction costs for new plants and expansion of manufacturing capacity.
- As a result of the cyberattack, orders and sales for certain products were negatively affected.
Invalidation: The isolated read changes if AMGN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind AMGN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
REGNRegeneron Pharmaceuticals, Inc.competitorMay 1, 2026 ▾
“On March 9, 2026, Amgen responded to Regeneron’s 2024 Complaint, denying infringement and asserting counterclaims seeking declaratory judgment that the asserted patents are not infringed, invalid, and/or unenforceable, and counterclaims for Sherman Act (15 U.…”
AZNAstraZeneca PLCpartnerFeb 13, 2026 ▾
“AstraZeneca plc We are in a collaboration with AstraZeneca for the development and commercialization of TEZSPIRE.”
Depended on by
PODD21.0% of PODDcustomerMay 6, 2026 ▾
“21 Table of Contents Drug Delivery Substantially all of our Drug Delivery revenue consists of sales of pods to Amgen for use in the Neulasta ® Onpro ® kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 32 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
AMGN is currently a Follower in the organic co-movement group Drug Manufacturers - General. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.